Summary:
- The article examines the clinical safety profile and potential long-term health implications of GLP-1 receptor agonists, such as semaglutide and tirzepatide, which are widely prescribed for weight management and type 2 diabetes.
- It highlights the necessity for ongoing longitudinal research to better understand the systemic effects of sustained medication use, particularly regarding gastrointestinal health, muscle mass preservation, and the management of potential side effects over several years.